MBK faces fresh scrutiny over Osstem Implant restructuring

Following the Homeplus debacle, MBK Partners has come under fresh scrutiny over restructuring efforts at its portfolio company Osstem Implant, the country's largest dental manufacturer. Osstem Implant has reportedly been carrying out a de facto restructuring under which some employees are relieved of their existing duties and required to find new positions within the company on their own. Those who fail to secure a new role are reportedly placed on waiting-for-reassignment status until another p

By The Korea Herald